As many as 700 veterans with COVID-19 will take part in a clinical trial, to determine how effective convalescent plasma can be in treating those who are seriously ill with the disease.
Researchers are interested in the extent to which antibodies in convalescent plasma, which is donated by patients who contracted and survived COVID-19, could help seriously ill patients fight off the disease.
The trial, conducted by the Department of Veterans Affairs, will take place at VA medical centers across the country where COVID-19 patients are being treated.
Medical researchers will administer some very sick patients with convalescent plasma, while others would receive a saline placebo.
They will then track the recovery of the participants. As of now, the Food and Drug Administration has approved use of convalescent plasma to treat COVID-19 in emergency situations only. Researchers hope that further trials will help better determine how effective the protocol can be.